Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China

BACKGROUND: Acarbose is one of the optimal drugs for patients with the first diagnosis of type 2 diabetes mellitus (T2DM). But what kind of emerging patients has the best therapeutic response to acarbose therapy has never been reported. To this end, we investigated predictors of acarbose therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Rong, Zhao, Quanxi, Li, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580108/
https://www.ncbi.nlm.nih.gov/pubmed/36258236
http://dx.doi.org/10.1186/s40360-022-00621-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580108/
https://www.ncbi.nlm.nih.gov/pubmed/36258236
http://dx.doi.org/10.1186/s40360-022-00621-2

Ejemplares similares